Mr. Speaker, this is actually a question I had hoped to ask the parliamentary secretary, but time ran out. I know that the hon. member across the way is also the chair of the health committee, so I am hoping that she might be able to provide some information.
One thing we know is that the Minister of Health has said that the government will speed up the approval process for new suppliers. The question, though, is where will those suppliers be and will they be more generic producers or those of higher-priced prescription medications? This is something that is obviously of concern to the provincial health authorities and hospitals because their supplier was a generic supplier. If the alternative suppliers the government says it is looking to expedite are basically non-generic brand names, this will obviously have severe cost implications.
I wonder if the member might be able to address that as a member on the government side and chair of the health committee. Does she know whether it will be generics or brand names?